Peplib

Boston, United States Founded: 2017 • Age: 9 yrs
Provider of peptide drug discovery and development services for global pharmaceutical industries
Request Access

About Peplib

Peplib is a company based in Boston (United States) founded in 2017 by Li Sean, Cheng Lei, and Gong Huanzhang.. Peplib has raised $34.22 million across 1 funding round from investors including Fortune Capital, CAS Investment Partners and CDH. Peplib operates in a competitive market with competitors including Liberation Labs, NJ Bio, Kinaxo Biotechnologies, Shantani Proteome Analytics and Scala Biodesign, among others.

  • Headquarter Boston, United States
  • Founders Li Sean, Cheng Lei, Gong Huanzhang
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $34.22 M (USD)

    in 1 rounds

  • Latest Funding Round
    $34.22 M (USD), Series A

    May 12, 2021

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal
People of Peplib
Headcount 1-10
Employee Profiles 5
Employee Profiles
People
Li Yilong
Director, Medicinal Chemistry
People
Huiqing Liu
Senior Vice President
People
Xiangqun Li
Co-Founder & CEO
People
Huanzhang Gong
Co-Founder & SVP

Unlock access to complete

Teams

Unlock access to complete

Funding Insights of Peplib

Peplib has successfully raised a total of $34.22M through 1 strategic funding round. The most recent funding activity was a Series A round of $34.22 million completed in May 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 1
  • Last Round Series A — $34.2M
  • First Round

    (12 May 2021)

  • Investors Count 6
Date Amount Transaction Name Valuation Lead Investors Investors
May, 2021 Amount Series A - Peplib Valuation CDH
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Peplib

Peplib has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Fortune Capital, CAS Investment Partners and CDH. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Private equity and private debt firm focused on multiple sectors
Founded Year Domain Location
Healthcare startups are funded by HLC venture capital firm.
Founded Year Domain Location
-
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Peplib

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Peplib

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Peplib Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Peplib

Peplib operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Liberation Labs, NJ Bio, Kinaxo Biotechnologies, Shantani Proteome Analytics and Scala Biodesign, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Fermentation products are manufactured and commercialized via CRO services.
domain founded_year HQ Location
Clinical development services are provided for biotechnology applications.
domain founded_year HQ Location
Chemical proteomics for cellular target profiling and drug discovery services
domain founded_year HQ Location
Drug discovery services are delivered via chemical-proteomics technologies.
domain founded_year HQ Location
Computational protein design solutions are delivered at scale.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Peplib

Frequently Asked Questions about Peplib

When was Peplib founded?

Peplib was founded in 2017 and raised its 1st funding round 4 years after it was founded.

Where is Peplib located?

Peplib is headquartered in Boston, United States. It is registered at Boston, Massachusetts, United States.

Is Peplib a funded company?

Peplib is a funded company, having raised a total of $34.22M across 1 funding round to date. The company's 1st funding round was a Series A of $34.22M, raised on May 12, 2021.

What does Peplib do?

Peplib was founded in 2017 in Boston, United States, within the biotech sector. Services in peptide drug discovery and development are offered to global pharmaceutical and biotech companies. A novel technology platform based on cyclic peptides is employed to encode and compress information, supporting drug innovation processes. Operations focus on advancing peptide-based therapeutics for industry partners.

Who are the top competitors of Peplib?

Peplib's top competitors include Liberation Labs, NJ Bio and Shantani Proteome Analytics.

Who are Peplib's investors?

Peplib has 6 investors. Key investors include Fortune Capital, CAS Investment Partners, CDH, Honghui Fund, and Cowin Capital.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available